β-blocker use in elderly patients with coronary heart disease

Age and Ageing

Volumn 29, Issue 1, 2000, Pages 17-21

  Kelly, James ^a   Kelleher, Kevin ^a  

^a QUEEN MARY S HOSPITAL   (United Kingdom)

Author keywords

blockers; Coronary heart disease; Myocardial infarction

Indexed keywords

ALTEPLASE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL;

ACUTE HEART INFARCTION; DRUG EFFICACY; DRUG TOLERABILITY; GERIATRIC PATIENT; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; PRIORITY JOURNAL; Q WAVE; REVIEW; SIDE EFFECT; UNSTABLE ANGINA PECTORIS;

ADRENERGIC BETA-ANTAGONISTS; AGED; CORONARY DISEASE; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL INFARCTION; RISK FACTORS; TREATMENT OUTCOME;

EID: 0033955598     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Wang TJ, Stafford RS. National patterns and predictors of beta blocker use in patients with coronary artery disease. Arch Intern Med 1998; 158: 1901-6.
2. ISIS 1 Collaborative Group (First International Study of Infarct Survival). Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS 1. Lancet 1986; 2: 57-66.
3. Anon. Intravenous beta blockade in acute myocardial infarction. Br Med J 1998; 317: 226-7.
4. Roberts R, Rogers WJ, Mueller HS et al. Immediate vs deferred beta blockade following thrombolytic therapy in patients with acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 2-B study. Circulation 1991; 83: 422-37.
5. ISIS 4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS 4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669-82.
6. Rich MW Therapy for acute myocardial infarction. Clin Geriatr Med 1996; 12: 141-68.
7. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta blockade on mortality among high risk and low risk patients after myocardial infarction. N Engl J Med 1998; 339: 489-97.
8. Yusuf S, Wittes J, Friedman L Overview of results of randomised clinical trials in heart disease. 2. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA 1988; 260: 2259-63.
9. Heidenreich PA, Mcdonald KM, Hastie T et al. Metanalysis of trials comparing beta blockers, calcium antagonists and nitrates for stable angina. JAMA 1999; 281: 1927-36.
10. Pepine CJ, Cohn PF, Deedwania PC. Effects of treatment on outcome in mildly symptomatic patients with ischaemia during daily life. The Atenolol Silent Ischaemia Study (ASIST). Circulation 1994; 90: 762-8.
11. Nidorf SM, Parsons RW, Thompson PL et al. Reduced risk of death at 28 days in patients taking a beta blocker before admission to hospital with myocardial infarction. Br Med J 1990; 300: 71-4.
12. Fox KM, Chopra MP, Portal RW et al. Long term beta blockade: possible protection from myocardial infarction. Br Med J 1975; 117-9.
13. North of England Stable Angina Guideline Development Group. North of England evidence based guidelines development project: summary version of evidence based guideline for primary care management of stable angina. Br Med J 1996; 312: 827-32.
14. Lechat P, Packer M, Chalon S et al. Clinical effects of beta adrenergic blockade in chronic heart failure. Circulation 1998; 98: 1184-91.
15. Doughty RN, Rodgers A, Sharpe N et al. Effects of beta blocker therapy on mortality in patients with heart failure. Eur Heart J 1997; 18: 560-5.
16. Anon. The evidence for beta blockers in heart failure (Editorial). Br Med J 1999; 318: 824-5.
17. CIBIS 2 Investigators and Committees. The cardiac insufficiency bisoprolol study 2 (CIBIS 2): a randomised trial. Lancet 1999; 353: 9-13.
18. MERIT-HF study group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 1999; 353: 2001-7.
19. Heidenreich P, Lee T, Massie BM. Effect of beta blockade on mortality in patients with heart failure: a metanalysis of randomised clinical trials. J Am Coll Cardiol 1997; 30: 27-34.
20. Packer M, Bristow MR, Cohn JN et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-55.
21. Mangano DT, Layug EL, Wallace A et al. Effect of atenolol on mortality and cardiovascular morbidity after non-cardiac surgery. N Engl J Med 1996; 335: 1713-20.
22. Soumerai SB, McLaughlin TJ, Spiegelman D et al. Adverse outcomes of underuse of beta blockers in elderly survivors of acute myocardial infarction. JAMA 1997; 277: 115-21.
23. Gurwitz JH, Goldberg RJ, Chen Z et al. Beta blocker therapy in acute myocardial infarction: evidence for underutilisation in the elderly. Am J Med 1992; 93: 605-10.
24. Viskin S, Kitzis I, Lev E et al. Treatment with beta adrenergic blocking agents after myocardial infarction: from randomised trials to clinical practice. J Am Coll Cardiol 1995; 25: 1327-32.
25. Mendelson G, Aronow WS. Underutilisation of beta blockers in older patients with prior myocardial infarction or coronary artery disease in an academic, hospital-based geriatrics practice. J Am Geriatr Soc 1997; 45: 1360-1.
26. Barakat K, Wilkinson P, Deaner A et al. How should age affect management of acute myocardial infarction? A prospective cohort study. Lancet 1999; 353: 955-9.
27. Ayanian JZ, Hauptman PJ, Guadagnoli E et al. Knowledge and practice of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med 1994; 331: 1136-42.
28. Gurwitz JH, Nananda F, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992; 268: 1417-22.
29. Beta Blocker Heart Attack Trial Research Group. A randomised trial of propranolol in patients with acute myocardial infarction. 2. Morbidity results. JAMA 1983; 250: 2814-9.
30. Gundersen T. Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction. Br Heart J 1983; 50: 135-9.
31. The Norwegian Multicentre Study Group. Timolol induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981; 304: 801-7.
32. Hjalmarson A, Herlitz J, Malek I et al. Effect on mortality of metoprolol in acute myocardial infarction. Lancet 1981; 2: 823-7.
33. Julian DG, Jackson FS, Prescott RJ et al. Controlled trial of sotalol for one year after myocardial infarction. Lancet 1982; 1: 1142-7.
34. Chadda K, Goldstein S, Byington R et al. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation 1986; 73: 503-10.
35. Hansteen V, Moinichen E, Lorentsen E. One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. Br Med J 1982; 284: 155-60.
36. Lichstein E, Hager D, Gregory JJ et al. For the Multicentre Diltiazem post Infarction Research Group. Relation between beta adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure. J Am Coll Cardiol 1990; 16: 1327-32.
37. Kennedy HL, Brooks MM, Barker AH et al. Beta blocker therapy in the cardiac arrhythmia suppression trial. Am J Cardiol 1994; 74: 674-80.
38. Yusuf S, Peto R, Lewis J et al. Beta blockade during and after myocardial infarction: an overview of the randomised trials. Prog Cardiovasc Dis 1985; 27: 335-71.
39. Dahlof B, Lindholm LH, Hansson L et al. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-5.
40. Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J 1986; 293: 1145-8.
41. Psaty BM, Smith NL, Siscovick DS et al. Health outcomes associated with antihypertensive therapies used as first line agents: a systematic review and meta-analysis. JAMA 1997; 277: 739-45.
42. Taylor SH, Silke B. Haemodynamic effects of beta blockade in ischaemic heart failure. Lancet 1981; 2: 835-7.
43. Olsson G, Lubsen J, Van Es G et al. Quality of life after myocardial infarction: effect of long-term metoprolol on mortality and morbidity. Br Med J 1986; 292: 1491-3.
44. Dahlof C, Dimenas E, Kendall M et al. Quality of life in cardiovascular diseases: emphasis on beta blocker treatment. Circulation 1991; 84 (suppl. 6): 108-18.
45. Park KC, Forman DE, Wei JY. Utility of beta blockade treatment for older postinfarction patients. J Am Geriatr Soc 1995; 43: 751-5.
46. Danforth J, Ports TA. Using beta blockers after myocardial infarction in the elderly. Geriatrics 1985; 40: 75-85.